Isis Pharmaceuticals (ISIS) forms an alliance with Roche (RHHBY.OB) to utilize Isis' technology...

|By:, SA News Editor

Isis Pharmaceuticals (ISIS) forms an alliance with Roche (RHHBY.OB) to utilize Isis' technology to develop innovative treatments for Huntington's disease. The companies will look to advance Isis' lead drug candidate which works by blocking the huntingtin protein. Isis will receive an upfront payment of $30M and may reap $362M in milestone payments and licensing fees going forward.